Hestia Insight Inc. (HSTA)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Hestia Insight Inc. (HSTA) with AI Score 39/100 (Weak). Hestia Insight Inc. is a strategic consulting and capital market advisory firm focused on micro, small, and medium-sized companies. Market cap: 0, Sector: Technology.
Last analyzed: Mar 16, 2026Hestia Insight Inc. (HSTA) Technology Profile & Competitive Position
Hestia Insight Inc. provides strategic consulting and capital market advisory services, primarily targeting micro, small, and medium-sized companies in the healthcare, biotech, and fintech sectors. Additionally, they offer healthcare management, technology development, and sales support, positioning them as a multifaceted service provider in specialized markets.
Investment Thesis
Hestia Insight Inc. presents a unique investment proposition as a consulting and advisory firm operating at the intersection of healthcare, biotech, and fintech. The company's focus on micro, small, and medium-sized businesses allows it to cater to a niche market often underserved by larger consulting firms. Key value drivers include the potential for revenue growth through expansion of its service offerings and client base within its target sectors. However, investors may want to evaluate the risks associated with the company's small size, limited resources, and dependence on key personnel. The company's P/E ratio is -0.78 and Beta is -0.31 as of March 16, 2026.
Based on FMP financials and quantitative analysis
Key Highlights
- Hestia Insight Inc. operates with a small team of 3 employees, indicating a lean operational structure.
- The company's focus on micro, small, and medium-sized businesses in healthcare, biotech, and fintech allows for specialized service offerings.
- Hestia Insight provides a diverse range of services, including strategic consulting, capital market advisory, healthcare management, and technology development.
- The company's negative P/E ratio of -0.78 suggests that it is currently not profitable.
- The company's beta of -0.31 indicates a low correlation with the overall market, potentially offering some downside protection.
Competitors & Peers
Strengths
- Specialized focus on healthcare, biotech, and fintech sectors.
- Integrated service offerings covering consulting, advisory, and technology development.
- Agile and responsive due to small company size.
- Established presence in Las Vegas.
Weaknesses
- Limited financial resources and capital.
- High dependence on key personnel.
- Small team size may limit scalability.
- OTC market listing may reduce investor confidence.
Catalysts
- Upcoming: Potential partnerships with fintech companies to expand service offerings in the fintech sector.
- Ongoing: Increasing demand for healthcare technology solutions for neurological and psychiatric disorders.
- Ongoing: Expansion of healthcare management services to address the needs of micro and small healthcare providers.
Risks
- Potential: Limited financial resources may constrain growth initiatives and expansion plans.
- Potential: Dependence on key personnel could disrupt operations if they leave the company.
- Ongoing: Intense competition from larger consulting firms with greater resources and brand recognition.
- Potential: Evolving regulatory landscape in healthcare and fintech may require costly compliance efforts.
- Ongoing: OTC market listing may reduce investor confidence and limit access to capital.
Growth Opportunities
- Expansion of Healthcare Technology Development: Hestia Insight can capitalize on the growing demand for innovative healthcare technologies by expanding its development capabilities. The global healthcare technology market is projected to reach $280 billion by 2028, presenting a significant opportunity for Hestia Insight to develop and commercialize new solutions for neurological and psychiatric disorders. Timeline: 2-3 years.
- Strategic Partnerships with Fintech Companies: Collaborating with emerging fintech companies to provide specialized consulting services can drive growth. The fintech market is experiencing rapid growth, with a projected market size of $509 billion by 2029. Hestia Insight can leverage its expertise in capital markets and healthcare to offer valuable insights to fintech companies seeking to disrupt the healthcare industry. Timeline: 1-2 years.
- Increased Focus on Healthcare Management Services: The demand for efficient healthcare management services is increasing as healthcare providers seek to optimize operations and improve patient outcomes. Hestia Insight can expand its healthcare management offerings to address this need, targeting micro and small healthcare providers that may lack the resources to implement sophisticated management systems. Timeline: Ongoing.
- Geographic Expansion Beyond Las Vegas: Hestia Insight can explore opportunities to expand its geographic reach beyond Las Vegas, targeting other regions with a high concentration of healthcare, biotech, and fintech companies. This expansion can be achieved through strategic partnerships, remote service delivery, and the establishment of satellite offices. Timeline: 3-5 years.
- Development of Proprietary Healthcare Analytics Platform: Creating a proprietary healthcare analytics platform can provide Hestia Insight with a competitive advantage and generate recurring revenue streams. This platform can leverage data analytics and machine learning to provide insights into patient behavior, treatment outcomes, and market trends, enabling healthcare providers to make more informed decisions. Timeline: 2-3 years.
Opportunities
- Expansion into new geographic markets.
- Development of proprietary healthcare technology solutions.
- Strategic partnerships with complementary businesses.
- Increased demand for specialized consulting services in target sectors.
Threats
- Intense competition from larger consulting firms.
- Evolving regulatory landscape in healthcare and fintech.
- Economic downturn impacting client spending.
- Technological disruptions rendering existing services obsolete.
Competitive Advantages
- Specialized expertise in the intersection of healthcare, biotech, and fintech.
- Focus on micro, small, and medium-sized businesses, a niche often underserved by larger firms.
- Integrated service offerings spanning consulting, advisory, technology development, and sales support.
About HSTA
Hestia Insight Inc., formerly known as Luxshmi Investments, Inc. until its name change in May 2019, is a Las Vegas-based firm providing strategic consulting and capital market advisory services. The company focuses on serving micro, small, and medium-sized enterprises within the healthcare, biotech, and fintech sectors. Hestia Insight offers a range of services, including healthcare management and patient services, development of healthcare technologies and analysis for neurological and psychiatric disorders, and medical supply sales support and management. The company also provides sales and marketing guidance to its clients. Hestia Insight's multifaceted approach aims to support its clients through various stages of growth and development, leveraging its expertise in both the financial and healthcare technology domains. The company operates with a small team of three employees.
What They Do
- Provides strategic consulting services to micro, small, and medium-sized companies.
- Offers capital market advisory services.
- Delivers healthcare management and patient services.
- Develops healthcare technologies and analysis for neurological and psychiatric disorders.
- Provides medical supply sales support and management.
- Offers sales and marketing guidance and services.
Business Model
- Generates revenue through consulting fees for strategic advisory services.
- Earns fees from capital market advisory services, such as assisting with fundraising and M&A transactions.
- Derives income from healthcare management and patient service contracts.
- Potentially generates revenue from the licensing or sale of developed healthcare technologies.
Industry Context
Hestia Insight Inc. operates within the competitive landscape of consulting and advisory services, specifically targeting the healthcare, biotech, and fintech sectors. These sectors are characterized by rapid innovation, evolving regulatory environments, and significant capital flows. The market for consulting services in these sectors is driven by the need for specialized expertise in areas such as regulatory compliance, technology adoption, and market access. Hestia Insight's focus on micro, small, and medium-sized businesses positions it to capitalize on the demand for tailored solutions in these dynamic industries.
Key Customers
- Micro-sized companies in the healthcare sector.
- Small-sized businesses in the biotech industry.
- Medium-sized enterprises in the fintech sector.
Financials
Chart & Info
Hestia Insight Inc. (HSTA) stock price: Price data unavailable
Latest News
-
Hovde Group Upgrades SouthState Bank (SSB) to Outperform
Yahoo Finance · Mar 25, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HSTA.
Price Targets
Wall Street price target analysis for HSTA.
MoonshotScore
What does this score mean?
The MoonshotScore rates HSTA's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Edward C. Lee
Managing Director
Edward C. Lee serves as the Managing Director of Hestia Insight Inc., overseeing a small team of three employees. Information regarding his detailed career history, education, and previous roles is not available. His leadership is pivotal in guiding the strategic direction and operational activities of the company, particularly in the areas of consulting and capital market advisory services.
Track Record: Due to limited information available, Edward C. Lee's specific achievements and strategic decisions at Hestia Insight Inc. cannot be comprehensively assessed. However, under his leadership since May 2019, the company has focused on providing services to micro, small, and medium-sized companies in the healthcare, biotech, and fintech sectors.
HSTA OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Hestia Insight Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited or no financial disclosure, which increases investment risk. Unlike companies listed on major exchanges like NYSE or NASDAQ, OTC Other companies face fewer regulatory requirements, potentially leading to less transparency and greater volatility.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited financial disclosure increases information asymmetry and investment risk.
- Low trading volume and wide bid-ask spreads can make it difficult to buy or sell shares.
- Lack of regulatory oversight increases the potential for fraud and manipulation.
- OTC Other companies may have a higher risk of delisting or going out of business.
- Limited analyst coverage and institutional interest can result in less price discovery and valuation uncertainty.
- Verify the company's registration and legal standing.
- Review available financial statements and disclosures, if any.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the company's capital structure and ownership.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- Company's incorporation date and history.
- Physical business address and contact information.
- Presence of a functional website and online presence.
- Industry affiliations and memberships.
- Positive client testimonials or case studies (if available).
Common Questions About HSTA
What does Hestia Insight Inc. do?
Hestia Insight Inc. operates as a strategic consulting and capital market advisory firm, primarily serving micro, small, and medium-sized companies within the healthcare, biotech, and fintech sectors. The company offers a suite of services, including healthcare management, technology development for neurological and psychiatric disorders, and sales support. This multifaceted approach positions Hestia Insight as a comprehensive service provider, aiming to support its clients' growth and development through specialized expertise.
What do analysts say about HSTA stock?
As of March 16, 2026, there is no available analyst coverage for Hestia Insight Inc. (HSTA). Given its OTC Other listing and small market capitalization of $0.00B, the company does not attract significant attention from major brokerage firms or research institutions. Investors should conduct their own thorough due diligence and consider the risks associated with investing in thinly traded, micro-cap stocks with limited public information. The company's P/E ratio is -0.78 and Beta is -0.31.
What are the main risks for HSTA?
Hestia Insight Inc. faces several key risks, including its limited financial resources, dependence on key personnel, and intense competition from larger consulting firms. Its OTC Other listing presents additional risks related to limited liquidity, regulatory oversight, and financial disclosure. The evolving regulatory landscape in healthcare and fintech could also pose challenges, requiring costly compliance efforts. Investors should carefully consider these risks before investing in HSTA.
What are the key factors to evaluate for HSTA?
Hestia Insight Inc. (HSTA) currently holds an AI score of 39/100, indicating low score. Key strength: Specialized focus on healthcare, biotech, and fintech sectors.. Primary risk to monitor: Potential: Limited financial resources may constrain growth initiatives and expansion plans.. This is not financial advice.
How frequently does HSTA data refresh on this page?
HSTA prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven HSTA's recent stock price performance?
Recent price movement in Hestia Insight Inc. (HSTA) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Specialized focus on healthcare, biotech, and fintech sectors.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider HSTA overvalued or undervalued right now?
Determining whether Hestia Insight Inc. (HSTA) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying HSTA?
Before investing in Hestia Insight Inc. (HSTA), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited information available on Hestia Insight Inc. due to its OTC listing and small market capitalization.
- Financial data is limited and may not be fully reliable.
- AI analysis pending, which may provide additional insights.